Valuation: Illumina, Inc.

Market Cap 28.78B 25.17B 23.23B 21.4B 40.35B 2,771B 41.24B 278B 109B 1,357B 108B 106B 4,673B P/E 2026 *
40.6x
P/E 2027 * 33.4x
Enterprise Value 29.28B 25.6B 23.62B 21.76B 41.04B 2,818B 41.94B 282B 111B 1,380B 110B 108B 4,753B EV / Sales 2026 *
6.41x
EV / Sales 2027 * 5.91x
Free-Float
75.39%
Yield 2026 *
-
Yield 2027 * -
1 day-1.89%
1 week-3.67%
Current month+6.15%
1 month+13.62%
3 months+40.63%
6 months+31.77%
Current year+42.31%
1 week 184.02
Extreme 184.02
194.18
1 month 158.91
Extreme 158.91
196.66
Current year 112.65
Extreme 112.65
196.66
1 year 88
Extreme 88
196.66
3 years 68.7
Extreme 68.7
196.66
5 years 68.7
Extreme 68.7
526
10 years 68.7
Extreme 68.7
555.77
Manager TitleAgeSince
Chief Executive Officer 51 25/09/2023
Director of Finance/CFO 50 15/04/2024
Chief Tech/Sci/R&D Officer 55 29/05/2025
Director TitleAgeSince
Director/Board Member 65 28/07/2016
Director/Board Member 66 01/01/2017
Director/Board Member 65 05/02/2019
Date Insider Type Main position Quantity % Market Cap.
30/06/26 Free

Director

142 0.0001%
30/06/26 Free

Director

167 0.0001%
30/06/26
Corvex Management LP
OtherCompany 0 0%
Change 5-day change 1-year change 3-year change Capi.($)
-1.89%-3.67%+92.50%-0.27% 28.78B
-1.97%+1.48%+27.90%+0.59% 202B
-0.58%+4.01%+5.45%-15.26% 145B
-14.15%-16.07%-32.62%-2.42% 142B
-1.32%-2.13%-57.33%-16.97% 66.32B
-2.40%-6.13%+12.60%-8.19% 50.58B
-0.11%+2.15%-23.83%-32.04% 44.81B
-3.41%-1.59%+15.90%+9.78% 38.44B
-2.44%-2.16%+27.43%+36.27% 37.13B
-4.00%-2.52%-16.41%-22.92% 29.89B
Average -1.68%+0.84%+5.16%-5.14% 78.54B
Weighted average by Cap. -1.27%+1.70%+1.71%-5.58%

Financials

2026 *2027 *
Net sales 4.57B 4B 3.69B 3.4B 6.41B 440B 6.55B 44.08B 17.31B 215B 17.16B 16.79B 742B 4.83B 4.22B 3.9B 3.59B 6.77B 465B 6.92B 46.59B 18.3B 228B 18.14B 17.74B 784B
Net income 723M 633M 584M 538M 1.01B 69.65B 1.04B 6.98B 2.74B 34.1B 2.72B 2.66B 117B 871M 762M 703M 648M 1.22B 83.9B 1.25B 8.41B 3.3B 41.08B 3.27B 3.2B 141B
Net Debt 492M 430M 397M 365M 689M 47.32B 704M 4.74B 1.86B 23.17B 1.85B 1.81B 79.8B -222M -194M -179M -165M -311M -21.33B -317M -2.14B -839M -10.44B -832M -814M -35.97B
Logo Illumina, Inc.
Illumina, Inc. specializes in DNA sequencing and array-based technologies, serving customers in research, clinical and applied markets. The Company's products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Its comprehensive line of products addresses the scale of experimentation and breadth of functional analysis to advance disease research, drug development, and the development of molecular tests. It also specializes in data-driven proteomics technology. Its products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training.
Employees
8,625
Date Price Change Volume
17/07/26 $186.65 -1.89% 1,249,245
16/07/26 $190.25 +1.66% 1,140,846
15/07/26 $187.15 -2.12% 1,782,478
14/07/26 $191.20 +0.61% 1,994,908
13/07/26 $190.05 -0.08% 1,198,925
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
190.25USD
Average target price
167.63USD
Spread / Average Target
-11.89%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ILMN Stock